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Dengue viruses (DVs) are responsible for the most
medically relevant arboviral diseases. However, the
molecular interactions mediating DV entry are poorly
understood. We determined that TIM and TAM
proteins, two receptor families that mediate the
phosphatidylserine (PtdSer)-dependent phagocytic
removal of apoptotic cells, serve as DV entry factors.
Cells poorly susceptible to DV are robustly infected
after ectopic expression of TIM or TAM receptors.
Conversely, DV infection of susceptible cells is in-
hibited by anti-TIM or anti-TAM antibodies or knock-
down of TIM and TAM expression. TIM receptors
facilitate DV entry by directly interacting with virion-
associated PtdSer. TAM-mediated infection relies
on indirect DV recognition, in which the TAM ligand
Gas6 acts as a bridging molecule by binding to
PtdSer within the virion. This dual mode of virus
recognition by TIM and TAM receptors reveals how
DVs usurp the apoptotic cell clearance pathway for
infectious entry.
INTRODUCTION
Dengue disease, which is caused by four dengue virus (DV) sero-
types (DV1 to DV4), has emerged as a major global health
problem during the last decades (Halstead, 2007; Kyle and
Harris, 2008). It is estimated that 50–100 million dengue cases
occur annually, with more than 2.5 billion people at risk of infec-
tion. Infection by any of the four serotypes causes disease,
ranging from mild fever to life-threatening dengue hemorrhagic
fever (DHF) and dengue shock syndrome (DSS) (Halstead,
2007; Kyle and Harris, 2008). Despite the importance and
increasing incidence of DV as a human pathogen, there is
currently no licensed vaccine against DV, and the lack of anti-
viral drugs severely restricts therapeutic options.
DV entry into target cells is a promising target for preventive as
well as therapeutic antiviral strategies since it is a major determi-544 Cell Host & Microbe 12, 544–557, October 18, 2012 ª2012 Elsevnant of host-range, cellular tropism, and viral pathogenesis.
During primary infection, DV enters host cells by clathrin-medi-
ated endocytosis (Krishnan et al., 2007; van der Schaar et al.,
2008), a process driven by the interaction between viral particles
and cellular receptors. Virus-receptor complexes are then
targeted to early endosomes, where the acidic environment
triggers an irreversible trimerization of the viral E glycoprotein
that results in fusion of the viral and cell membranes (Bressanelli
et al., 2004; Modis et al., 2004) and the release of genomic RNA
into the cytosol. To date, themolecular bases of DV-host interac-
tions leading to virus entry are poorly understood and little is
known about the identity of DV cellular receptor(s). DVs infect
a wide range of cell types (Anderson, 2003; Balsitis et al.,
2009; Couvelard et al., 1999; Jessie et al., 2004; Wu et al.,
2000) and may therefore exploit multiple different receptors or
use widely expressed entry molecules. Earlier studies indicated
that DV virions make initial contact with the host by binding to
membrane-associated heparan-sulfate proteoglycans (Chen
et al., 1997). These molecules recognize positively charged
residues on the surface of E protein and are thought to concen-
trate the virus at the target cell surface prior to its interaction with
entry factors. Numerous cellular proteins such as heat shock
protein 70 (HSP70), HSP90, GRP78/Bip, the lipopolysaccharide
receptor CD14, or the 37/67 kDa high-affinity laminin have been
proposed as putative DV entry receptors (Ansarah-Sobrinho
et al., 2007; Cabrera-Hernandez et al., 2007; Jindadamrong-
wech et al., 2004; Thepparit and Smith, 2004). However, their
function in viral entry remains obscure. To date, the known
cellular receptors that promote DV infection are DC-SIGN in
dendritic cells (Fernandez-Garcia et al., 2009; Lozach et al.,
2005; Tassaneetrithep et al., 2003), L-SIGN in liver endothelial
cells (Tassaneetrithep et al., 2003), and the mannose receptor
in macrophages (Miller et al., 2008a), all of which are C-type
lectins (Robinson et al., 2006) that bind glycans on the viral
envelope glycoprotein E (Dejnirattisai et al., 2011; Lozach
et al., 2005; Miller et al., 2008a). However, DVs also infect cells
that lack these lectins, indicating that other unidentified recep-
tor(s) should exist.
In this study, we have conducted a gain-of-function cDNA
screen to identify plasma membrane proteins that enhance DV
infection. We discovered that TIM and TAMproteins, two distinctier Inc.
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phosphatidylserine (PtdSer)-dependent phagocytic engulfment
and removal of apoptotic cells, are DV entry factors. We found
that TIM proteins bind directly to PtdSer on the surface of DV
particles, while TAM proteins bind indirectly to viral PtdSer via
their natural ligands Gas6 and ProS, which act as bridging
molecules. These results indicate that DVs have evolved to
exploit TIM and TAM receptors and the apoptotic cell clearance
pathway for entry into target cells and suggest that inhibitors
of these receptors may represent a promising class of antiviral
compounds.
RESULTS
A cDNA Screen Identifies Cell Surface Receptors
that Enhance DV2 Infection
To identify DV entry factors, we carried out a gain-of-function
cDNA screen for human genes that render the poorly susceptible
cell line 293T (Lozach et al., 2005) infectable by the DV2 strain
JAM (DV2-JAM). This screen identified L-SIGN, confirming the
validity of our approach, but also T cell immunoglobulin domain
and mucin domain (TIM)-3, TYRO3, and AXL as potential DV
receptors (data not shown). These belong to two distinct families
of transmembrane receptors that bind directly (TIMs) or indi-
rectly (TAMs) to phosphatidylserine (PtdSer), an ‘‘eat me’’ signal
that promotes the engulfment of apoptotic cells (Freeman et al.,
2010; Lemke and Rothlin, 2008; Ravichandran, 2011). We further
characterized the role of these receptors and of PtdSer during
DV infection.
TIM Receptors Enhance DV Infection
TIM-3, along with TIM-1 and TIM-4, is a cell surface glycoprotein
that binds to PtdSer on the surface of apoptotic cells (Freeman
et al., 2010) and are thought to be key regulators of immune
tolerance (Freeman et al., 2010; Umetsu et al., 2008). To examine
whether expression of TIM receptors enhances DV infection,
293T cells stably expressing TIM-1 and TIM-4 (which were not
initially present in our cDNA library) or TIM-3 (Figure 1A) were
generated and challenged with mosquito-derived DV2-JAM at
different multiplicities of infection (moi) (Figure 1B). Parental cells
were minimally infected by the virus even at high moi. TIM-3
expression resulted in a modest increase in the percentage of
infected cells. Strikingly, TIM-1 or TIM-4 expression potentiated
infection up to 500-fold. Of note, infection was assessed by
measuring newly synthesized NS1 proteins, indicating that
TIMs mediate productive DV infection. We obtained similar
results using DV2 particles grown in Vero cells (Figure S1A).
Titration of cell-free supernatants collected from cells chal-
lenged with DV2-JAM showed that TIM-1- and TIM-4-infected
cells released large amounts of infectious particles (Figure 1C).
Interestingly TIM-mediated enhancement of DV infection was
also observed when HeLa cells were used as recipients (Fig-
ure S1B) and did not occur in cells expressing BAl1 (Figure S1C),
a recently identified PtdSer receptor (Park et al., 2007). TIM-1 or
TIM-4 also enhances infection by the three other DV serotypes
(Figure 1D). The laboratory-adapted DV2 New Guinea C (NGC)
and 16681 strains infected parental 293T cells, suggesting that
some DV isolates may use other receptor(s) (Figure S1D).
However, DV2 NGC or 16681 infection was also stronglyCell Hostenhanced by TIM-1 or TIM-4 (Figure S1D). To determine whether
TIM receptors mediated infection by other viral species, we chal-
lenged TIM-1- and TIM-4-expressing cells with West Nile virus
(WNV), yellow fever virus vaccine strain (YFV-17D), and herpes
simplex virus 1 (HSV-1). Viral infection was quantified by flow
cytometry using specific Ab (Figure 1E). TIM-1 and TIM-4
massively enhanced WNV infection, slightly upregulated sensi-
tivity to YFV-17D, but had no effect on HSV-1. Together, these
data indicate the PtdSer receptors TIM-1 and TIM-4, and to
a lesser extent TIM-3, are cellular factors promoting flavivirus
infection.
TIM Receptors Directly Interact with DV Particles
and Enhance Virus Internalization
To determine whether DV virions directly bind TIM receptors, we
conducted a pull-down assay with soluble TIM-Fc. We incu-
bated DV2 particles with TIM-1-Fc or TIM-4-Fc, or as a positive
control with DC-SIGN-Fc and protein G-sepharose beads.
Precipitated virus was analyzed by western blotting using the
anti-DV E protein mAb 4G2. DV bound to TIM-1, TIM-4, and
DC-SIGN constructs and not to NKG2D-Fc or IgG1-Fc negative
control constructs (Figure 2A). DV-TIM-1 interaction was also
confirmed by ELISA using TIM-1-Fc coating on well plates (Fig-
ure 2B). The binding of DV to TIM-1-Fcwas inhibited by anti-TIM-
1 polyclonal Ab but not by control Ig (Figure S2). DV/TIM-1-Fc
interaction was inhibited by EDTA (Figure S2), suggesting that
it is Ca2+ dependent. Moreover, DV efficiently attached to
293T-TIM-1 and 293T-TIM-4 but not to control cells (Figure 2C).
Together, these results show that TIM-1 and TIM-4 bind DV and
mediate virus attachment to target cells.
We then investigated whether TIM expression enhances DV
internalization. We challenged parental, TIM-1, or TIM-4-ex-
pressing 293T cells with DV2-JAM for 2 hr at 37C. Cells were
treated with proteinase K to eliminate bound virus, as previously
described (Fernandez-Garcia et al., 2011). Total RNA was ex-
tracted and viral RNA levels were quantified by qPCR. TIM
receptors strongly increased DV RNA uptake into 293T cells
(18-fold and 10-fold enhancement with TIM-1 and TIM-4,
respectively) (Figure 2D). In a second approach, we expressed
TIM-1, TIM-4, and DC-SIGN into CHO-745 cells, which are
a mutant CHO cell line that does not express cell surface hep-
aran sulfate proteoglycans (Esko et al., 1985). Cells were incu-
bated with purified DV2-JAM particles for 1 hr at 4C and shifted
to 37C for 45 min to allow endocytosis, as previously described
(Fernandez-Garcia et al., 2011). Virus uptake was monitored by
fluorescence microscopy using anti-DV E mAb 4G2 in cells
that were permeabilized, or not, with saponin (Figure 2E). We
observed a massive intracellular accumulation of DV E protein
in permeabilized cells expressing TIM-1, TIM-4, or DC-SIGN,
but not in parental CHO (Figure 2E). Few virus particles were
detected in cells that were not permeabilized. To study the
role of TIM-1 cytoplasmic tail in enhancement of infection,
we transfected 293T cells with TIM-1 WT or a TIM-1 mutant
lacking its entire cytoplasmic tail (TIM-1 Dcyt). Cell surface
expression levels of TIM-1Dcyt were found to be similar to
WT TIM-1 (Figure 2F), however our infection studies show that
TIM-1Dcyt is still able to enhance DV2-JAM infection. Thus,
TIM-1 enhances DV entry via a mechanism that is independent
of its cytoplasmic tail.& Microbe 12, 544–557, October 18, 2012 ª2012 Elsevier Inc. 545
Figure 1. TIM Receptors Enhance DV Infection
(A) Surface levels of TIM molecules on 293T parental (red line) and transduced cells (blue line) were evaluated by flow cytometry using polyclonal anti-TIM
antibodies. Gray shading represents cell staining with a control IgG.
(B–E) Parental and 293T cells expressing TIM receptors (B) were challenged with DV2-JAM. Infection levels were assessed by flow cytometry using the anti-NS1
mAb. Parental, TIM-expressing 293T (C) were infected with DV2-JAM. Supernatants were collected 48 hr later. Virus titers were determined by plaque assay and
expressed as plaque forming unit per ml. TIM receptors are used by the four DV serotypes (D). TIM receptors are shared by other flaviviruses (E). Data are
represented as mean ± SEM of at least three independent experiments. See also Figure S1.
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with DV Particles
TIMs specifically recognize PtdSer exposed on the surface of
apoptotic cells (Freeman et al., 2010; Kobayashi et al., 2007;
Santiago et al., 2007a, 2007b). We therefore investigated
whether PtdSer is associated with DV virions. For this aim, we
purified DV2-JAM particles using sucrose gradient as previously
described (Navarro-Sanchez et al., 2003). Purified viruses retain
their ability to use TIM receptors (Figure S3). Sucrose gradient
purified DV2-JAM were coated on ELISA wells and incubated
with the anti-PtdSer mAb 1H6. We found that the 1H6 mAb,546 Cell Host & Microbe 12, 544–557, October 18, 2012 ª2012 Elsevbut not its isotype control, bound to DV-coated ELISA plates
(Figure 3A). To examine if TIM-mediated DV infection is depen-
dent on viral PtdSer, we preincubated purified DV2 with annexin
V (ANX5), a PtdSer-binding protein. ANX5 inhibited infection of
293T-TIM-1 and 293T-TIM-4 but not of 293T-DC-SIGN cells
(Figure 3B). Structural studies of the TIM immunoglobulin (Ig)
domain previously demonstrated that PtdSer binds in a cavity
built up by the CC0 and FG loops, termed the metal ion-depen-
dent ligand-binding site (MILIBS) (Kobayashi et al., 2007;
Santiago et al., 2007a, 2007b). We designed mutants of highly
conserved amino acids (TIM-1 N114A or D115A, TIM-4 N121A)ier Inc.
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tion (Kobayashi et al., 2007; Santiago et al., 2007a, 2007b). We
found that the mutated TIM receptors were unable to mediate
DV2 infection even though they were correctly expressed at
the cell surface (Figure 3C). Together, these data suggest that
PtdSer is associated with the surface of DV virions and is
required for TIM-mediated DV infection.
TAM Ligands Bind to Viral PtdSer and Bridge DV
Particles to TAM Receptors
TYRO3 and AXL belong to the TAM family, a group of three
receptor protein tyrosine kinases that mediate the clearance of
apoptotic cells (Lemke and Rothlin, 2008). The TAM ligands
Gas6 and ProS are essential to this process (Ferna´ndez-Ferna´n-
dez et al., 2008; Lemke and Rothlin, 2008). Via their N-terminal
Gla domain, they recognize the PtdSer expressed on apoptotic
cells and bridge these cells to a TAM receptor on the surface
of phagocytes (Lemke and Rothlin, 2008).
We found that 293T cells expressing high levels of TYRO3 or
AXL (Figure 4A) were efficiently infected by DV2-JAM as as-
sessed by immunofluorescence (Figure 4B) and flow cytometry
using anti-NS1 Ab (Figure 4C) and released many infectious
particles (Figure S4A). Ectopic expression of AXL and TYRO3
in 293T cells strongly potentiated infection by the four different
DV serotypes and by WNV, but not by HSV-1 (Figures S4B and
S4C). In addition, TYRO3 and AXL act at a very early stage during
DV infection by enhancing virus uptake (Figure S4D). We ex-
pressed WT, kinase-dead forms of AXL (K567A mutation of the
ATP-binding site) and AXL DCyt (complete cytoplasmic domain
deletion) in 293T cells and compared their ability to mediate
endocytosis and infection. Interestingly, our data indicated that
tailless and kinase-dead AXL variants are unable to enhance
DV infection (Figure S4E). However, these mutated receptors
mediate DV internalization as efficiently as AXL WT (Figure S4F).
This suggests that the AXL cytoplasmic tail and tyrosine kinase
activity are essential for enhancement of DV infectivity but
dispensable for virus endocytosis.
We found that DV did not interact directly with TYRO3 or AXL,
since we were unable to immunoprecipitate virus particles with
TAM-Fc constructs (Figure S4G). However, incubation of DV
particles with purified Gas6 (Figure 4D) or with fetal bovine serum
(FBS) (Figure S4H), in which ProS is present at300 nM (Ferna´n-
dez-Ferna´ndez et al., 2008), potentiated virus binding to TAM-
expressing cells. Thus, DV attachment to TYRO3 and AXL likely
occurs only in the presence of TAM ligands. Moreover, AXL-
mediated enhancement of DV infection was no longer detectable
in serum-free medium, but was restored after preincubating DV
particles with Gas6 (Figure 4E) or FBS (Figure S4I). Similar results
were observed with TYRO3 (Figure S4J). Consistent with these
findings, an AXL receptor mutated in the Gas6 binding site
(AXL E66R/T84R) (Sasaki et al., 2006) did not enhance infection
of DV complexed to Gas6, even though it was expressed at the
cell surface (Figure 4E). To further investigate the importance of
viral PtdSer in TAM-mediated enhancement of DV infection, we
used Gas6DGla, a Gas6 variant impaired for PtdSer binding (Fig-
ure S4K). Gas6DGla did not interact with DV particles coated
onto plate wells (Figure 4F) and failed to bridge DV virions to
TYRO3-Fc and AXL-Fc (Figure 4G). Pretreatment of TAM-ex-
pressing 293T cells with Gas6DGla abrogated DV infection (Fig-Cell Hosture 4H). As for TIM receptors, ANX5 inhibited DV infection of
293T cells expressing TYRO3 or AXL (Figure S4L), strongly sug-
gesting that the TAM effect is PtdSer-dependent. Together,
these data support a tripartite model, whereby TAM ligands
bind to PtdSer associated with DV particles and bridge virions
to TAM receptors.
TIM-1 and AXL Expression Correlate with DV
Susceptibility
We next investigated the relationship between TIM and TAM
expression on the cell surface and the efficiency of DV infection
in various cell lines. We detected high levels of TIM-1 and/or AXL
expression on the surface of A549, Vero, Cos-7, and Huh7 5.1
cells (Figure 5A), all of which are readily infected by DV2-JAM
(Figure 5B). 293T, U937, or RAJI cells, which are poorly suscep-
tible to DV2-JAM (Figure 5B), lack TIM-1 and AXL (Figure 5A). To
investigate whether enhanced infectivity associated with TIM
and TAM expression correlate with increased virus binding, we
performed binding studies using the A549 cell line that endoge-
nously expresses TIM-1 and AXL (Figure 5A). A549 were also
chosen because they express low levels of heparan sulfate
proteoglycan, which has been described as an attachment
receptor for DV (Chen et al., 1997) and thus may interfere with
the binding studies. We found that DV2 interacts efficiently
with A549 cells. Interestingly, we observed that anti-TIM1 Ab
significantly inhibits DV2 binding, while anti-AXL polyclonal has
only a modest effect (Figure 5C). These data suggest that
TIM-1 is an important receptor that mediates DV attachment to
A549 cells.
Endogenous TIM-1 and AXL Mediate DV Infection
We then analyzed the effects of neutralizing anti-TIM1 and/or
anti-AXL Abs on DV infection of different cell lines. The Huh7
5.1 cell line expresses only TIM-1 (Figure 5A). An anti-TIM-1
Ab inhibited DV2 infection but not HSV-1 infection (Figure 6A).
The A549 cell line expresses both TIM-1 and AXL (Figure 5A).
DV2 infection was partly reduced with an anti-TIM-1 or anti-
AXL Ab administrated alone, while the two Abs in combination
fully inhibited DV2 (Figures 6B and 6C) and DV3 (Figure S5A)
but not HSV-1 infection. Similar results were obtained on
Vero cells, which express TIM-1 and AXL (Figure S5B). We
then silenced TIM-1 or AXL expression by RNA interference in
A549 cells (Figure 6D). DV infection was reduced in AXL-
silenced cells and almost totally inhibited in TIM-1 silenced cells
(Figure 6D), indicating an important role of TIM-1 in DV infection
of A549. Notably, as for TIM- and TAM-293T-transfected cells,
ANX5 blocked DV infection of A549 cells (Figure 6E). Alto-
gether, these results show that TIM and TAM receptors may
naturally cooperate to promote DV infection and that viral
PtdSer mediates infection in cells endogenously expressing
the receptors.
Epithelial cells and astrocytes are DV targets in vivo (Balsitis
et al., 2009; Ramos et al., 1998; Limon-Flores et al., 2005).
Primary kidney epithelial cells and astrocytes express AXL
(Figures 6F and 6G) but not TYRO3, TIM-1 or TIM-4 (not shown).
DV infection was significantly reduced by an anti-AXL Ab in both
cell types (Figures 6F and 6G). Silencing AXL in astrocytes also
significantly decreased DV3 infection (Figure S5C). Therefore,
as illustrated for AXL, the PtdSer receptors identified in our& Microbe 12, 544–557, October 18, 2012 ª2012 Elsevier Inc. 547
Figure 2. TIM-1 and TIM-4 Molecules Bind to DV and Enhance Virus Endocytosis
(A) Western blot analysis of DV2-JAMpreincubatedwith control Fc, NKG2D-Fc, TIM-1-Fc, or TIM-4-Fc bound to protein A-agarose beads. Pulled-down viruswas
detected using the 4G2 anti-DV E protein mAb.
(B) Control Fc, NKG2D-Fc, or TIM-1-Fc were coated on 96-well plates and incubated with DV2-JAM for 1 hr at 4C. Bound virus was detected using the bio-
tinylated 4G2 mAb and HRP-conjugated streptavidin See also Figure S2.
(C) Cells transfected with an empty vector or plasmids encoding TIM-1 or TIM-4 were incubated 1 hr at 4C with DV2-JAM. Bound virus was detected by flow
cytometry using the 4G2 mAb.
(D) Cells were incubated with DV2-JAM for 2 hr at 37C and treated with proteinase K. Total RNA was extracted from infected cells, and DV2 viral RNA level was
determined by real-time quantitative PCR with human GAPDH as endogenous control. Results are expressed as the fold difference using expression in 293T
infected cells as calibrator value.
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Figure 3. TIM-1 and TIM-4 Molecules Recognize PtdSer Associated with DV Particles
(A) Sucrose gradient purified DV2 particles were coated on well plates and incubated with the anti-PtdSer 1H6 mAb. See also Figure S3.
(B) DV2-JAM preincubated with Annexin V (ANX5; 25 mg/ml) was used to infect the indicated cells. Infection was normalized to infection without ANX5.
(C) TIMmoleculesmutated in the PtdSer binding domain do notmediate DV infection. Left panel: Cell surface expression ofWT and TIM-1 or TIM-4mutants. Right
panel: Transfected cells were infected with DV2-JAM. Data are represented as mean ± SEM of at least three independent experiments.
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observation that should be relevant for DV pathogenesis.
DISCUSSION
The present study adds significant insights into the molecular
interactions that occur between DV and the host cell during viral
entry.We show that TIM and TAMproteins, two receptor families
involved in apoptotic cell recognition and clearance, mediate DV
infection. TIM- and TAM-mediated enhancement of virus infec-
tion is dependent on PtdSer associated with DV particles. This
supports a model by which DV use a strategy of ‘‘apoptotic
mimicry’’ to infect target cells (Laliberte and Moss, 2009; Mercer
and Helenius, 2008).
We provide strong evidence indicating that TIM and TAM
receptors are cellular factorsmediating DV binding and infection.(E) Parental and CHO-745 cells expressing TIM-1, TIM-4, or DC-SIGN were incu
labeled with DAPI (blue) and the anti-DV E protein 4G2 (green) to detect virus up
(F) 293 T cells were transfected with plasmid encoding for TIM-1 WT, TIM-1 lack
were stained for TIM-1 expression (left panel) and challenged with DV2-JAM (rig
experiments.
Cell HostFirst, ectopic expression of TIM and TAM rendered human cells
susceptible to DV infection. Second, Ab against TIM and TAM
receptors inhibited DV infection in cells naturally expressing
these proteins. Third, in analyses of DV infectivity, evidence of
loss-of-function was obtained using RNA interference. Finally,
binding studies revealed that TIM and TAM molecules interact
with DV particles and enhance virus endocytosis. However,
our data suggest that TIM and TAM proteins do not directly
promote DV internalization. We observed that the TIM-1 cyto-
plasmic tail is dispensable for DV entry, indicating that TIM-
mediated enhancement of infection relies mainly on the receptor
ectodomain. We propose that TIM-1 may act primarily as a
tethering/attachment receptor that binds and enhances DV
infection without any obligatory role in virus endocytosis. This
is consistent with the proposed role of TIM receptors during
the engulfment of apoptotic cells (Park et al., 2009; Todabated with DV2-JAM for 1 hr at 4C and shifted at 37C for 45 min. Cells were
take in unpermeabilized and permeabilized cells.
ing its entire cytoplasmic tail (TIM-1 Dcyt), or an empty vector (pcDNA3). Cells
ht panel). Data are represented as mean ± SEM of at least three independent
& Microbe 12, 544–557, October 18, 2012 ª2012 Elsevier Inc. 549
Figure 4. TYRO3 and AXL Enhance DV Infection
(A) Surface levels of TAM molecules on 293T parental (red) and cells stably expressing human TYRO3 and AXL (blue). Gray: isotype control Ab.
(B and C) Cells were challenged by DV2-JAM and infection was assessed 48 hr later. Immunofluorescence (B) with an anti DV prM glycoprotein (2H2) (red) and
DAPI (blue). Flow cytometry analysis (C) with an anti-NS1 mAb. See also Figure S4.
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enhancement of DV infection relies on still uncharacterized
cellular receptors. It is possible that TIM receptors pass the virus
in cis to another molecule that is ultimately responsible for virus
endocytosis, as we proposed for DC-SIGN-mediated DV entry
(Lozach et al., 2005). Alternatively, TIMs could also directly
associate with unknown molecules to form an entry complex
that coordinates virus endocytosis. Our data suggest that TIM
and TAM receptors may play distinct roles during DV infection.
We found that tailless and kinase-dead AXL variants are still
able to enhance DV endocytosis. However, and as shown for
Ebola and Lassa virus entry (Shimojima et al., 2007, 2012),
both mutated AXL molecules are unable to enhance DV infec-
tion, indicating that tyrosine kinase activity is important for AXL
potentiation of viral infection. These data suggest that AXL func-
tion is not restricted to enhance virus endocytosis but also to
initiate signaling that facilitates infection of the target cells. Of
note, Gas6 binding to TAM receptors has been shown to inhibit
innate inflammatory immune responses (Lemke and Rothlin,
2008), including signaling downstream of TLRs (Rothlin et al.,
2007). It is thus tempting to speculate that TAM ligation by DV
during entry may initiate signal transduction events that may
modulate host immune responses to potentiate a postendocytic
step of the DV life cycle.
In cells expressing both TIM-1 and AXL (such as A549 and
Vero), DV infection was partly reduced by anti-TIM-1 or anti-
AXL Ab administrated alone and completely inhibited by the
two Ab in combination. Thus, TIM-1 and AXL may cooperate to
mediate optimal DV infection. TAM receptors are known to
physically associate with non-TAM receptors by heterotypic
dimerization (Linger et al., 2008; Rothlin et al., 2007). One can
speculate that they may recruit TIM and/or additional receptors
to form a viral entry complex required for DV uptake and infection
(Figure 7A). DVs use the clathrin-mediated endocytosis as
a major entry route for internalization (Krishnan et al., 2007; van
der Schaar et al., 2008). It will be worth further assessment of
the role of the clathrin-dependent pathway and other endocytic
routes during TIM- and TAM-mediated enhancement of DV
infection.
The role played by TIM and TAMproteins during DV pathogen-
esis in vivo is currently unknown. In vivo, TIM and TAM receptors
are expressed in many cell types relevant to DV infection. AXL is
widely expressed (Lemke and Rothlin, 2008) with prominent
expression in macrophages, dendritic cells, and vascular endo-
thelia, and we show here that DV infection of cultured epithelial
cells and astrocytes is AXL-dependent. TIM-1 is abundant on
Th-2 T cells, mucosal epithelial cells, and mast cells; the last
have been recently identified as important DV target cells(D) Gas6 enhancesDV binding to TYRO3- and AXL-expressing cells. Cells were inc
(1 mg/ml) or PBS (mock). Mean fluorescent intensity was measured by flow cytom
(E) 293T cells expressing WT AXL or a molecule mutated in the Gas6-binding site
Gas6 (1 mg/ml) or PBS (mock). After 3 hr, medium was replaced by medium supp
expression.
(F) Plastic-coated DV2-JAM (107 FIU) was incubated with Gas6 or Gas6DGla (2 mg
Gas6 (10 mg/ml) Ab.
(G) Plastic-coated DV2-JAM particles (107 FIU) were incubated with the indica
(2 mg/ml). Bound Fc-chimeras were detected using an HRP-conjugated anti-hum
(H) Cells were incubated with Gas6DGla (1 mg/ml) for 30 min before and during a 3
three independent experiments. **p < 0.001, ***p < 0.0001. See also Figure S5.
Cell Host(Freeman et al., 2010; Kondratowicz et al., 2011; St John et al.,
2011). TIM-4 is present exclusively on antigen-presenting cells
(Kobayashi et al., 2007; Wong et al., 2010), which are sensitive
to DV infection and thought to play an important role in DV path-
ogenesis. Our data indicate that TIM and TAM usage is not
sufficient to explain DV tropism. Indeed, we have shown that
DVs can infect cells lacking these proteins, suggesting that other
cellular receptors that dictate virus tropism remain to be charac-
terized. However, our results suggest that TIM and TAM recep-
tors contribute to enhance infection of relevant target cells,
which may have important consequences for virus spread.
We reveal an unexpected role for PtdSer during DV infection.
Our data suggest that PtdSer is displayed on the surface of DV
particles and is important for TIM- and TAM-mediated infection.
In agreement with the binding of apoptotic cells to PtdSer recep-
tors (Ravichandran, 2011; Ravichandran and Lorenz, 2007), we
describe a dual mode of recognition of DV by TIM and TAM
receptors. TIM molecules directly interact with DV. Our muta-
genesis study of TIM strongly suggests that PtdSer associated
with DV particles binds to the MILIBS of the molecule. Indirect
recognition of DV is mediated by a TAM ligand such as Gas6,
which recognizes through its Gla domain viral PtdSer and
bridges DV virions to AXL and TYRO3. Together, these observa-
tions suggest that, by mimicking apoptotic bodies, DVs subvert
the apoptotic clearance function of TIM and TAM receptors to
enhance infection.
TIM and TAM proteins mediate the entry of other viruses
(Feigelstock et al., 1998; Kondratowicz et al., 2011; Morizono
et al., 2011; Shimojima et al., 2012, 2006). AXL and TIM-1 are
receptors for Ebola virus, which, like DV, infects a broad range
of cell types and causes hemorrhagic fever (Kondratowicz
et al., 2011; Shimojima et al., 2006). TIM-1-mediated Ebola infec-
tion depends on a direct interaction between the viral glycopro-
tein GP through residues outside the MILIBS (Kondratowicz
et al., 2011), indicating that DV and Ebola virus may use distinct
TIM-1 regions. A recent study also identified Gas6 and ProS as
‘‘bridging factors’’ that link PtdSer expressed on the viral enve-
lope of lentiviral pseudotypes and vaccinia virus to AXL ex-
pressed on the target cell (Morizono et al., 2011). Collectively,
these data suggest that TIM and TAM facilitation of viral infection
may represent a general mechanism exploited by viruses that
incorporate PtdSer in their membrane for optimal infection.
An interesting direction for future work is to identify how DVs
acquire this lipid and how PtdSer becomes accessible to TIM
and TAM receptors. The DV membrane is derived from the ER
of the infected cell upon budding. The ER membrane is known
to contain PtdSer in the lumenal leaflet (Leventis and Grinstein,
2010), which suggests an obvious mechanism through whichubated for 90min at 4Cwith DV2-JAM in serum-freemedium containing Gas6
etry and normalized to that in noninfected cells.
(E66R/T84R) were incubated with DV2-JAM in serum-free medium containing
lemented with 10% FBS. The inset displays wild-type and mutant AXL surface
/ml) for 1 hr. Bound Gas6 was detected by ELISA using a goat polyclonal anti-
ted Fc-chimeras (2 mg/ml) in the presence or absence of Gas6 or Gas6DGla
an IgG.
hr-incubation with DV2-JAM. Data are represented as mean ± SEM of at least
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Figure 5. TIM-1 and AXL Expression and DV Infection in Cell Lines
(A) Surface level of TIM-1 and AXL on cell lines was monitored by flow cytometry. Gray shading represents cell staining with a control Ab.
(B) The indicated cells were challenged with DV2-JAM.
(C) A549 cells were incubated with DV2-JAM for 1 hr at 4C in the presence of goat polyclonal anti-TIM-1, anti-AXL, or normal goat IgG as control. Mean
fluorescent intensity wasmeasured by flow cytometry and normalized to binding in presence of control IgG. Data are shown as one representative flow cytometry
analysis (left panel) and are represented as mean ± SEM of at least three independent experiments (right panel).
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However, the viral membrane does not appear to be readily
exposed to receptors at the virion surface. This is shown by552 Cell Host & Microbe 12, 544–557, October 18, 2012 ª2012 Elsevstructural studies, which have revealed that a closed icosahedral
shell of the envelope protein completely encloses the viral
membrane in mature DV particles (Kuhn et al., 2002). It isier Inc.
Figure 6. Endogenous TIM-1 and AXL Molecules Mediate DV Infection
(A and B) Huh7.5.1 (A) and A549 (B) cells were infected with the indicated DV strains or HSV-1 in the presence of polyclonal goat anti-TIM-1, anti-AXL, or normal
goat IgG as control. The levels of infected cells were normalized to infection in presence of control IgG.
(C) Representative immunofluorescence analysis of A549 infected with DV2-JAM in the presence of the indicated Ab. Green anti-prM 2H2, Blue DAPI. Scale bar:
100 mm.
(D) A549 cells were transfected by the indicated siRNA, and TIM-1 and AXL expression was assessed by flow cytometry after 2 days, at the time of infection. Cells
were infected with DV2-JAM or HSV-1. Infection was normalized to infection in nontargeting (siNT) siRNA-transfected cells.
(E) A549 cells were infected with DV2-JAM or HSV-1 preincubated with different concentrations of ANX5.
(F) and (G) Human primary kidney epithelial cells (F) or astrocytes (G) were infected with DV in the presence of control IgG or an anti-AXL Ab. Insets display AXL
cellular expression at the time of infection. Data are represented as mean ± SEM of at least three independent experiments. **p < 0.001, ***p < 0.0001. See also
Figure S6.
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Figure 7. Model of PtdSer Acquisition by DV Particles and the TIM and TAM Receptor-Mediated Enhancement of DV Infection
(A) Proposed model of direct and indirect (bridging) recognition of DV by the TIM and TAM receptors.
(B) Schematic representation of DV particle acquiring phosphatidylserine (PdtSer) upon budding into the ER lumen.
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fied receptors may display weak interactions with the E protein
that trigger opening of the icosahedral shell, leading to exposure
of viral membrane, as recently suggested by studies with Ab
complexes (Cockburn et al., 2012). Also, recent studies have
indicated that the majority of the DV particles released from
infected cells are partially mature virions, which display amixture
of immature and mature surfaces (Junjhon et al., 2010; Pierson
and Diamond, 2012; Plevka et al., 2011). These immature-like
regions could expose membrane patches, such that PtdSer
would be accessible for TIM and TAM interactions. Partially
mature virions result in an incomplete cleavage of the envelope
glycoprotein prM. Additional studies are thus required to eval-
uate whether modulation of the efficiency of the prM cleavage
impacts TIM and TAM receptor usage.EXPERIMENTAL PROCEDURES
cDNA Library Screening
We used sequence databases (SWISS-PROT, Uniprot, Human Protein
Reference Database) and selected 1728 full-length cDNAs encoding plasma
membrane receptors from an arrayed cDNA library cloned into the vector
pCMVSPORT6 (Porcel et al., 2004). In a first round of screening, 293T cells
were transfected for 4 hr with 216 pools of 8 cDNAs (1 mg each) in a 24-well
plate format following Lipofectamine LTX protocol. An equal amount of
a DC-SIGN cDNA dilution (diluted 1/8 in empty plasmid) was used as a positive
control. Empty vector was used as a negative control. Transfected cells were554 Cell Host & Microbe 12, 544–557, October 18, 2012 ª2012 Elsevchallenged with the DV2-JAM primary strain (moi = 2) and infection was
quantified 48 hr later by flow cytometry using the 2H2 anti-prM mAb. Pools
of cDNA that rendered 293T cells positive for prM protein intracellular staining
entered the second round of screening, in which single cDNAs from each
positive pool were tested as described above.
Viruses and Cells
The DV-1-TVP5175 strain, DV2-JAM strain (Jamaica), DV2-New Guinea C
strain, DV2-16881 strain, DV3-PAH881/88 strain (Thailand), DV4-1086 strain
and WNV (Israeli IS-98-STI strain) were propagated in AP61 cell monolayers
after having undergone limited cell passages. Virus titers were assessed by
flow cytometry analysis (FACS) on C6/36 cells and were expressed as FACS
infectious units (FIU). YFV was grown and titrated on Vero cells. HSV-1(F)
was propagated and titrated on Vero cells as described elsewhere (Taddeo
et al., 2004). HEK293T, CHO745 cells, Cos-7, A549, VERO, and Huh7 5.1 cells
(a gift of C.Rice, New York, USA) were maintained in DMEM supplemented
with 10% FBS, 1% penicillin/streptomycin. Human primary astrocytes and
epithelial cells were purchased from LONZA and cultured according to the
manufactured conditions.
Virus Pull-Down
DV particles (107 FIU) were incubated overnight at 4Cwith 2 mg of Fc-chimera
proteins in TBS, 10 mM CaCl2. BSA-saturated Protein G Sepharose beads
(GE Healthcare) were added and incubated for 4 hr at 4C. Beads were
washed with TBS, 10 mM CaCl2, 0.05% Tween, and bound material was
resolved in 1X Laemmli buffer in nonreducing conditions. Nitrocellulose-bound
E envelope glycoprotein was detected with the 4G2mAb andHRP-conjugated
rabbit anti-mouse IgG antibody (Sigma-Aldrich).
Cell-Binding Assay
Cells (4 3 105) were incubated with DV for 90 min at 4C in binding buffer
(DMEM, NaN3 0.05%) containing either 2% BSA or 5% FBS. Cells wereier Inc.
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with the virus. The cells werewashed twicewith cold binding buffer and fixed in
PBS-PFA 2%at 4C. Cell surface-absorbed DV particles were stained with the
4G2 Ab, then analyzed by flow cytometry. For bridging assays, cells were
simultaneously incubated with virus and Gas6 (10 mg/ml).
ELISA Binding
For detecting direct interactions between TIM-Fc and DV, Fc-fused proteins
were first coated (400 ng/well) in TBS supplemented with 10 mM CaCl2 on
96-well plates overnight at 4C. Wells were washed with TBS 10 mM CaCl2
and saturated for 2 hr at 37C with TBS 10 mM CaCl2, 2% BSA. DV particles
(5.106 FIU/well) were added and incubated for 2 hr at 4C. Bound particles
were detected with the biotinylated 4G2 antibody (1 mg/ml) and Horseradish
peroxydase (HRP)-conjugated Streptavidine (R&D systems). For Gas6
bridging experiments, DV particles were incubated with Gas6 proteins
(2 mg/ml) and Fc-chimera proteins (2 mg/ml) for 1 hr at 37C in TBS 10 mM
CaCl2, 0.05% Tween. Bound Fc-chimeras were detected with HRP-conju-
gated rabbit anti-human IgG antibody. For Gas6 binding experiments, DV
particles (107 FIU) or PtdSer (3-sn-Phosphatidyl-L-serine from bovine brain)
were coated overnight at 4C. Wells were incubated with Gas6 proteins
(2 mg/ml) and extensively washed. Bound Gas6 proteins were labeled with
a goat anti-Gas6 polyclonal antibody and detected with a HRP-conjugated
donkey anti-goat IgG antibody. PtdSer was detected on coated DV particles
(107 FIU) using anti-PtdSer 1H6 mAb (10 mg/ml) and a HRP-conjugated rabbit
anti-mouse IgG antibody in PBS BSA 2%.
Immunofluorescence Assay
Cells were cultured on Lab-Tek II-CC2 Chamber Slide (Nunc, Roskilde,
Denmark) and infected with DV2-JAM. Cells were fixed with PBS-PFA 4%,
permeabilized with 0.05% saponin in PBS, and incubated with the anti-prM
Ab 2H2. Slides were mounted with ProLong Gold antifade reagent containing
4,6-diamidino-2-phenylindole (DAPI) for nuclei staining. For internalization
assay, prechilled CHO745 cells were incubated with viral particles at 4C for
1 hr. Cells were washed with cold PBS to remove unbound particles and
shifted at 37C for 30 min. Cells were fixed with PBS-PFA 4% before immuno-
staining with 4G2 anti-E antibody under permeabilized and unpermeabilized
conditions.
RNA Interference
Cells were transiently transfected using the Lipofectamine RNAiMax protocol
(Life Technologies) with 10 nM final siRNAs as described previously. After
48 hr, cells were infected at the indicated moi, and infected cell percentages
were quantified 24 hr postinfection by flow cytometry. Pools of siRNAs
(ON-TARGETplus SMARTpool) used in this study were from Dharmacon:
TIM-1 (L-019856-00), AXL (L-003104-00). Nontargeting negative control (NT)
was used as control.
Flow Cytometry Analysis
Flow cytometry analysis was performed as previously described (Lozach et al.,
2005). DV infection was detected using the anti-prM 2H2mAb or an NS1 mAb.
HSV-1 infection was detected using the anti-ICP4 mAb (clone 10F1, Santa
Cruz Biotechnology).
Inhibition of Infection Assay
Cells were incubated for 30 min prior to infection with media containing the
indicated quantities of goat anti-TIM and/or anti-TAM polyclonal antibodies.
Identical concentrations of purified normal goat IgG were used as control.
Cells were then infected for 3 hr incubation in the presence of inhibitors,
washed, and incubated with culture medium. Infection was quantified by
flow cytometry as indicated above.
RNA Purification, Reverse Transcription, and Real-Time qPCR
Total RNA was extracted from infected cells, using an RNeasy Mini Kit
(QIAGEN, Courtaboeuf, France) with on-column DNase digestion, and stored
at 20C. cDNA was synthesized from 500 ng total isolated RNA by random
priming-reverse transcription with the SuperScript VILO cDNA Synthesis Kit
(Invitrogen by Life Technologies). Real-time quantitative PCR (qPCR) was
performed using the Fast SYBR GreenMaster Mix Kit (Invitrogen by Life Tech-
nologies) on an Applied Biosystems 7500 Fast real-time PCR system
(Life Technologies). The primers for viral RNA quantification were designed
with PrimerExpress software V2.0 (Life Technologies) within the conserved
region of the capsid gene of DV2-JAM (Forward primer 50-TTCTCACTTGGA
ATGCTGCAA-30; Reverse primer 50-GCCACAAGGGCCATGAAC-30) and
QuantiTect primers for GAPDH were purchased from QIAGEN. RelativeCell Hostexpression quantification was performed based on the comparative CT
Method, using GAPDH as endogenous reference control.
Statistical Analyses
Graphical representation and statistical analyses were performed using
Prism5 software (GraphPad Software). Unless otherwise stated, results are
shown as means ± standard deviation (SD) from three independent experi-
ments. Differences were tested for statistical significance using the paired
two-tailed t test.
SUPPLEMENTAL INFORMATION
Supplemental Information includes five figures and Supplemental Experi-
mental Procedures and can be found with this article online at http://dx.doi.
org/10.1016/j.chom.2012.08.009.
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